FDA Approves 2nd Car-T Therapy – for Adult Lymphoma

The U.S. Food and Drug Administration today approved a 2nd cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment. “Today marks another milestone in the development of a whole new scientific paradigm for the treatment of serious diseases” said FDA Commissioner Scott Gottlieb, M.D.

Cure The Future helps 1st time gene discovery

Your Cure The Future donations have supported a ground-breaking discovery which may help find new treatments for cancer and other diseases. Dr Ulf Schmitz and Centenary Institute’s Gene & Stem Cell Therapy Program, led by Professor John Rasko AO, have – for the first time – discovered a common pattern in the process of gene regulation in humans, mice, dogs, chickens and zebrafish. A better understanding of this common process will help develop novel therapies and possible cures for diseases.

Genetic Testing & Life Insurance

Bioethicists are calling for tighter regulation of the insurance industry when it comes to genetic testing. Researchers say that some Australians have been unable to take out insurance policies because of results contained in their genetic tests. They say this is...